Is lymphoma occurring in the elderly the same disease?

被引：7

作者：

Armitage, James O. ^{[1
]}

机构：

[1] Univ Nebraska Med Ctr, Dept Hematol, Omaha, NE 68198 USA

来源：

LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 01期

关键词：

D O I：

10.1080/10428190701742522

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：14 / 16

页数：3

共 11 条

[1]

Chan WC, 1997, ANN ONCOL, V8, P973

[2]

FU K, 2007, J CLIN ONCOL, pS451

[3]

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience [J].

Ganti, A. K. ;

Weisenburger, D. D. ;

Smith, L. M. ;

Hans, C. P. ;

Bociek, R. G. ;

Bierman, P. J. ;

Vose, J. M. ;

Armitage, J. O. .

ANNALS OF ONCOLOGY, 2006, 17 (06) :920-927

[4]

Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology [J].

Lim, Soon Thye ;

Hee, Siew Wan ;

Quek, Richard ;

Tao, Miriam .

LEUKEMIA & LYMPHOMA, 2008, 49 (01) :149-151

[5]

Elderly patients with non-Hodgkin's lymphoma: Population-based results in the Netherlands [J].

Maartense, E ;

Hermans, J ;

Kluin-Nelemans, JC ;

Kluin, PM ;

Van Deijk, WA ;

Snijder, S ;

Wijermans, PW ;

Noordijk, EM .

ANNALS OF ONCOLOGY, 1998, 9 (11) :1219-1227

[6]

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:: results of the NHL-B2 trial of the DSHNHL [J].

Pfreundschuh, M ;

Trümper, L ;

Kloess, M ;

Schmits, R ;

Feller, AC ;

Rübe, C ;

Rudolph, C ;

Reiser, M ;

Hossfeld, DK ;

Eimermacher, H ;

Hasenclever, D ;

Schmitz, N ;

Loeffler, M .

BLOOD, 2004, 104 (03) :634-641

[7]

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma [J].

Rosenwald, A ;

Wright, G ;

Chan, WC ;

Connors, JM ;

Campo, E ;

Fisher, RI ;

Gascoyne, RD ;

Muller-Hermelink, HK ;

Smeland, EB ;

Staudt, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (25) :1937-1947

[8]

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma [J].

Rosenwald, A ;

Wright, G ;

Leroy, K ;

Yu, X ;

Gaulard, P ;

Gascoyne, RD ;

Chan, WC ;

Zhao, T ;

Haioun, C ;

Greiner, TC ;

Weisenburger, DD ;

Lynch, JC ;

Vose, J ;

Armitage, JO ;

Smeland, EB ;

Kvaloy, S ;

Holte, H ;

Delabie, J ;

Campo, E ;

Montserrat, E ;

Lopez-Guillermo, A ;

Ott, G ;

Muller-Hermelink, HK ;

Connors, JM ;

Braziel, R ;

Grogan, TM ;

Fisher, RI ;

Miller, TP ;

LeBlanc, M ;

Chiorazzi, M ;

Zhao, H ;

Yang, LM ;

Powell, J ;

Wilson, WH ;

Jaffe, ES ;

Simon, R ;

Klausner, RD ;

Staudt, LM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) :851-862

[9]

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma [J].

Savage, KJ ;

Monti, S ;

Kutok, JL ;

Cattoretti, G ;

Neuberg, D ;

de Leval, L ;

Kurtin, P ;

Dal Cin, P ;

Ladd, C ;

Feuerhake, F ;

Aguiar, RCT ;

Li, SG ;

Salles, G ;

Berger, F ;

Jing, W ;

Pinkus, GS ;

Habermann, T ;

Dalla-Favera, R ;

Harris, NL ;

Aster, JC ;

Golub, TR ;

Shipp, MA .

BLOOD, 2003, 102 (12) :3871-3879

[10]

A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA [J].

SHIPP, MA ;

HARRINGTON, DP ;

ANDERSON, JR ;

ARMITAGE, JO ;

BONADONNA, G ;

BRITTINGER, G ;

CABANILLAS, F ;

CANELLOS, GP ;

COIFFIER, B ;

CONNORS, JM ;

COWAN, RA ;

CROWTHER, D ;

DAHLBERG, S ;

ENGELHARD, M ;

FISHER, RI ;

GISSELBRECHT, C ;

HORNING, SJ ;

LEPAGE, E ;

LISTER, TA ;

MEERWALDT, JH ;

MONTSERRAT, E ;

NISSEN, NI ;

OKEN, MM ;

PETERSON, BA ;

TONDINI, C ;

VELASQUEZ, WA ;

YEAP, BY .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :987-994

← 1 2 →